Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides.

Institute of Evolution, University of Haifa, Mt. Carmel, Haifa 31905, Israel.
Applied Microbiology and Biotechnology (Impact Factor: 3.81). 11/2002; 60(3):258-74. DOI: 10.1007/s00253-002-1076-7
Source: PubMed

ABSTRACT The number of mushrooms on Earth is estimated at 140,000, yet maybe only 10% (approximately 14,000 named species) are known. Mushrooms comprise a vast and yet largely untapped source of powerful new pharmaceutical products. In particular, and most importantly for modern medicine, they represent an unlimited source of polysaccharides with antitumor and immunostimulating properties. Many, if not all, Basidiomycetes mushrooms contain biologically active polysaccharides in fruit bodies, cultured mycelium, culture broth. Data on mushroom polysaccharides have been collected from 651 species and 7 infraspecific taxa from 182 genera of higher Hetero- and Homobasidiomycetes. These polysaccharides are of different chemical composition, with most belonging to the group of beta-glucans; these have beta-(1-->3) linkages in the main chain of the glucan and additional beta-(1-->6) branch points that are needed for their antitumor action. High molecular weight glucans appear to be more effective than those of low molecular weight. Chemical modification is often carried out to improve the antitumor activity of polysaccharides and their clinical qualities (mostly water solubility). The main procedures used for chemical improvement are: Smith degradation (oxydo-reducto-hydrolysis), formolysis, and carboxymethylation. Most of the clinical evidence for antitumor activity comes from the commercial polysaccharides lentinan, PSK (krestin), and schizophyllan, but polysaccharides of some other promising medicinal mushroom species also show good results. Their activity is especially beneficial in clinics when used in conjunction with chemotherapy. Mushroom polysaccharides prevent oncogenesis, show direct antitumor activity against various allogeneic and syngeneic tumors, and prevent tumor metastasis. Polysaccharides from mushrooms do not attack cancer cells directly, but produce their antitumor effects by activating different immune responses in the host. The antitumor action of polysaccharides requires an intact T-cell component; their activity is mediated through a thymus-dependent immune mechanism. Practical application is dependent not only on biological properties, but also on biotechnological availability. The present review analyzes the pecularities of polysaccharides derived from fruiting bodies and cultured mycelium (the two main methods of biotechnological production today) in selected examples of medicinal mushrooms.

  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This review highlights the importance to people of some types of wild fungi considered in the context of non­wood forest products. Macrofungi are used both for food and medicine proposes. Substances isolated from the higher Basidiomycetes and Ascomycetes mushrooms express promising immune modulating, antitumor, antiviral, antibacterial and antidiabetic properties. They have been, and are presently, used against cancer in some countries in Far East as well as in the United States of America and Canada. Their useful properties are mainly conferred by biologically-active polysaccharides present in the fruiting bodies and cultured mycelium. A few dozen different polysaccharide antitumor agents have been developed from such species as: Ganoderma lucidum, Lentinus edodes, Schizophylum commune, Trametes versicolor and Inonotus obliquus. In the review some other fungi and their properties are also described. The information is provided to widen our knowledge of the importance of the organisms that live in forest ecosystems.
    Forest Research Papers. 01/2012; 73(4).
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 3 factor, 3 level Box-Behnken factorial design combined with response surface methodology was used to optimize the fermentation process for production of extracellular polysaccharide (EPS) from Hirsutella sinensis. The 3 independent variables were temperature (X1), initial pH (X2), and the glucose concentration (X3). Experimental data were fitted to a 2nd order polynomial equation using multiple regression. The optimal fermentation conditions of the production of EPS were a temperature of 18.21°C, an initial pH of 5.81, and a glucose concentration of 7.39 g/L. The maximum predicted EPS production of 2.41 g/L was close to the actual experimental EPS yield (2.42±0.038%), demonstrating the model validity. EPS from H. sinensis had a direct in vitro immuno-stimulating activity using murine macrophage RAW264.7 cells, and stimulated release of several major cytokines (IL-1β, NF-κB, TNF-α, and iNOS) in a dose-dependent manner.
    Food science and biotechnology 04/2014; 23(2):451-457. · 0.66 Impact Factor


Available from